Research suggests that certain compounds found in neem may have potential in addressing acne-related inflammation, with one 2025 study finding that gedunin, a neem-derived compound, reduced key inflammatory markers associated with Cutibacterium acnes activity in both cell-based experiments and a mouse model. That study indicated gedunin worked primarily by suppressing the NF-κB signaling pathway and inhibiting NLRP3 inflammasome activation, leading to lower levels of pro-inflammatory molecules such as IL-1β, TNF-α, and IL-6. However, the current evidence base is very limited, consisting only of preclinical laboratory and animal research, with no published human clinical trials yet establishing whether these findings translate to safe or effective acne treatment in people. Readers should be aware that results from cell and animal studies frequently do not replicate in human trials, and substantially more research would be needed before conclusions can be drawn about neem's therapeutic value for acne.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Gedunin Mitigates Cutibacterium acnes-Induced Skin Inflammation by Inhibiting... | Other | 2025 | Supports | 100 |